Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
+5.39M
-
Total reported value, excl. options
-
$411M
-
Value change
-
+$142M
-
Number of buys
-
61
-
Number of sells
-
-8
-
Price
-
$25.66
Significant Holders of 89bio, Inc. - Common Stock, par value $0.001 per share (ETNB) as of Q3 2020
70 filings reported holding ETNB - 89bio, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
89bio, Inc. - Common Stock, par value $0.001 per share (ETNB) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 148M outstanding shares and own 10.8% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.74M shares), ORBIMED ADVISORS LLC (3.73M shares), WELLINGTON MANAGEMENT GROUP LLP (1.82M shares), FRANKLIN RESOURCES INC (684K shares), EVENTIDE ASSET MANAGEMENT, LLC (675K shares), VANGUARD GROUP INC (548K shares), BlackRock Inc. (436K shares), ACUTA CAPITAL PARTNERS, LLC (418K shares), BANK OF AMERICA CORP /DE/ (386K shares), and Ikarian Capital, LLC (340K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.